Reimbursement Advisor
-
News
ACOG guidelines for HIV screening don’t always acknowledge coding reality
The College urges “opt-out” screening—but many states require that, even then, you counsel the patient and have her sign a consent form
Clinical Review
-
Clinical Review
The case for chemoprevention as a tool to avert breast cancer
Women at high risk of invasive breast cancer can elect chemoprevention with tamoxifen or raloxifene. An aromatase inhibitor may one day be an...
-
Clinical Review
UPDATE: ENDOMETRIAL CANCER
Are lymphadenectomy and external-beam radiotherapy valuable in women who have an endometrial malignancy? Debate over the standard of care...
Medicolegal Issues
-
Medicolegal Issues
“No-fault” insurance that covers a pregnancy and birth
The author envisions one-child-at-a-time policies that will blunt the OB malpractice crisis. Could it work?
Expert Commentary
-
Expert Commentary
Does cognitive function decline during the menopausal transition?
-
Expert Commentary
Are staples or sutures better for closing the skin at cesarean delivery?
Commentary
Medical Verdicts
-
Medical Verdicts
Medical Verdicts
NOTABLE JUDGMENTS AND SETTLEMENTS
News for Your Practice
-
News for Your Practice
Women given a diagnosis of CIN face an elevated risk of recurrence
The likelihood of recurrence depends on the grade of CIN, the treatment used, and the woman’s age.
From the Editor
-
From the Editor
We must take the lead in the battle against breast cancer
ObGyns have done so much to stop cervical cancer. Can’t we do more to reduce the risk of death from breast malignancy?